CD38 and metabolic dysfunction-associated steatotic liver disease: First, the pathogenesis of CD38 in NAFLD has not been adequately studied, and more studies are needed to demonstrate the correlation between CD38 and inflammation, abnormal accumulation of fatty acids, and insulin resistance.